LFD sensitivity: manufacturer reported versus laboratory evaluation
This report presents the comparison of the sensitivity data provided by the manufacturer in the instructions for use with that observed in the laboratories at Porton Down.
Documents
Details
This report presents the comparison of manufacturer reported sensitivity data, as reported in the instructions for use, with the sensitivity data observed in the Phase 3 evaluation at Porton Down between August 2020 and November 2022.
For more information, see the protocol for the evaluation of rapid diagnostic assays for specific SARS-CoV-2 antigens (lateral flow devices).